Larry L. Wood - Nov 10, 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, TAVR
Signature: Linda J. Park, Attorney-in-Fact
Stock symbol: EW
Transactions as of: Nov 10, 2021
Transactions value $: -$662,366
Form type: 4
Date filed: 11/10/2021, 04:38 PM
Previous filing: Oct 12, 2021
Next filing: Dec 10, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$276K	+7.83K	+2.1%	$35.20	380K	Nov 10, 2021	Direct	F1
transaction	EW	Common Stock	Sale	-$938K	-7.83K	-2.06%	$119.79	372K	Nov 10, 2021	Direct	F1
holding	EW	Common Stock						496	Nov 10, 2021	401(k)	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-7.83K	-50%	$0.00	7.83K	Nov 10, 2021	Common Stock	7.83K	$35.20	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.
F2	Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.